Residual substantia nigra neuromelanin in Parkinson’s disease is cross-linked to α-synuclein
- 21 January 2003
- journal article
- Published by Elsevier BV in Neurochemistry International
- Vol. 42 (7), 603-606
- https://doi.org/10.1016/s0197-0186(02)00161-4
Abstract
The pigmentation of substantia nigra pars compacta dopaminergic neurons is due to the presence of neuromelanin, an irregular macromolecular pigment belonging to the family of melanins. Depletion of neuromelanin in Parkinson’s disease is typically indicated by loss of brown color in this area. Unlike that from controls, the pigment extracted from substantia nigra of parkinsonian patients seems to be mainly composed by highly cross-linked, protease-resistant proteic material and the neuromelanin macromolecule appears to be a minor presence. In the present paper we describe the isolation by SDS-PAGE of this proteic component after cleavage of the melanin backbone under solubilizing conditions. A single band is observed, which has been identified as α-synuclein by western blotting. As expected, the same process performed on a control specimen did not show occurrence of any major proteic component. Nevertheless, extraction from a 91 years old control with Lewy bodies displayed minor α-synuclein immunoreactive aggregates, whereas inclusion of free α-synuclein was not observed at all. Results reported here support the view that α-synuclein accumulates within substantia nigra neurons and is entrapped in pigment granules during neuromelanin biosynthesis, i.e. before the melanin depletion characteristic of Parkinson’s disease starts.Keywords
This publication has 20 references indexed in Scilit:
- Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson diseaseNature Medicine, 2001
- Parkin and the Molecular Pathways of Parkinson's DiseaseNeuron, 2001
- Isolation and13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with parkinson's diseaseMovement Disorders, 2000
- Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson’s disease patients are consistent with protein aggregationNeurochemistry International, 2000
- Enhanced vulnerability to oxidative stress by α-synuclein mutations and C-terminal truncationNeuroscience, 2000
- Q-band EPR investigations of neuromelanin in control and Parkinson’s disease patientsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Parkinson's DiseaseNew England Journal of Medicine, 1998
- Structure/function in neuroprotection and apoptosisAnnals of Neurology, 1998
- Evidence for a Glycidic‐Lipidic Matrix in Human Neuromelanin, Potentially Responsible for the Enhanced Iron Sequestering Ability of Substantia NigraJournal of Neurochemistry, 1994
- NMR Studies of Melanins: Characterization of a Soluble Melanin Free Acid From Sepia InkPigment Cell Research, 1991